NCT07476378 2026-03-17
Archonc-001
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
Clinical Trials
25 trialsNCT07463976 2026-03-11
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
Not yet recruiting
NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
NCT07218341 2026-02-10
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Eli Lilly and Company
Phase 4 Not yet recruiting
NCT07024706 2026-01-21
MAVRiC
AstraZeneca
Phase 2 Not yet recruiting
NCT07194980 2026-01-09
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Fred Hutchinson Cancer Center
Phase 2 Not yet recruiting
NCT07286539 2025-12-16
PEPOH
University of Salamanca
Phase NA Not yet recruiting
NCT06792994 2025-12-02
CLL2000
German CLL Study Group
Not yet recruiting
NCT07225439 2025-11-06
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Case Comprehensive Cancer Center
Phase 1 Not yet recruiting
NCT06979076 2025-09-29
A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL
MingSight Pharmaceuticals, Inc
Phase 1/2 Not yet recruiting
NCT07162532 2025-09-09
Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients
Assiut University
Not yet recruiting
NCT07157579 2025-09-05
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
Sohag University
Not yet recruiting
NCT07113132 2025-08-08
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
Assiut University
Not yet recruiting
NCT06971848 2025-07-11
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT06862323 2025-06-13
Time Restricted Eating in Haematological Malignancies
British Columbia Cancer Agency
Phase 2 Not yet recruiting
NCT07020533 2025-06-13
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
City of Hope Medical Center
Phase 1 Not yet recruiting
NCT07003464 2025-06-04
Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study
The First Hospital of Jilin University
Phase 2 Not yet recruiting
NCT05371392 2024-06-20
Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia
Sohag University
Not yet recruiting
NCT06416267 2024-05-16
MBL RiskConseq
University of Haifa
Not yet recruiting
NCT06364033 2024-05-09
Biological and Clinical Efficacy of Shingrix in Patients With CLL
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Not yet recruiting
NCT05718986 2024-05-08
Familial_LPD
University of Haifa
Not yet recruiting
NCT06367374 2024-04-16
MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Not yet recruiting
NCT06084923 2024-04-10
Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not yet recruiting
NCT04790045 2023-10-03
LymBIO
IRCCS San Raffaele
Phase 4 Not yet recruiting
NCT05899543 2023-06-12
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
Power Life Sciences Inc.
Not yet recruiting